본문 바로가기
  • Home

Ortho-Cellular Nutrition Therapy (OCNT) Prescription for Patients with Bronchiectasis and End-stage Liver Cancer

  • CELLMED
  • Abbr : CellMed
  • 2022, 12(4), pp.18-18
  • DOI : 10.5667/CellMed.2022.018
  • Publisher : Cellmed Orthocellular Medicine and Pharmaceutical Association
  • Research Area : Medicine and Pharmacy > General Medicine
  • Received : November 24, 2022
  • Accepted : November 28, 2022
  • Published : November 30, 2022

Han Inhee 1

1독립연구자

Accredited

ABSTRACT

In Korea, liver cancer is the sixth most prevalent malignancy and the second leading cause of cancer-related mortality. The peak incidence of liver cancer deaths occurs between the ages of 40 and 59. (e.g. Yoon et al. 2021) The patient is a 69-year-old female with bronchiectasis as an underlying condition. She underwent left lower lobe resection for the disease, and in 2009 she was diagnosed with liver cancer and experienced a recurrence after a full recovery. In the case of such patients, the most effective OCNT prescription is recommended.

Citation status

* References for papers published after 2022 are currently being built.